Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized add-on zonisamide trial in adults with focal epilepsy
2005-000260-57Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of zonisamide in Focal Onset Epilepsy and epilepsy (3 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Change in seizure frequency weeks 13–16 vs. baseline. Started Feb 2005; status: completed.
02
Drugs
zonisamide
03
Conditions
Focal Onset Epilepsyepilepsy
Beyond the preview
Go deeper on 2005-000260-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000260-57.